Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease

Abstract excerpt

Hydroxyurea (HU) is not infrequently used in patients with sickle cell disease and myeloproliferative disorders. Despite murine data showing adverse effects on sperm counts, motility and morphology, there is little information on the effect of HU on human spermatogenesis. A retrospective review of four adult men who had semen analysis during HU therapy and in three cases after its cessation suggests that HU...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hemoglobinopathies and Related Disorders
• Share to Iron Metabolism and Disorders
• Share to Myeloproliferative Neoplasms: Diagnosis and Treatment